The global Respiratory Inhaler Devices Market is projected to reach USD 68.1 billion by 2036, rising from USD 38.0 billion in 2026 at a CAGR of 6.0%. This steady expansion reflects the mounting global burden of chronic respiratory diseases and the accelerating transition toward advanced, low-carbon, and digitally enabled inhalation therapies. As healthcare systems adapt to rising...